Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Neoplasms × Mycophenolic Acid × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Cutaneous 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 25 Lymphoma, Non-Hodgkin 25 Lymphoma, Follicular 25 Lymphoma, B-Cell, Marginal Zone 25 Leukemia, Lymphocytic, Chronic, B-Cell 25 Lymphoma, Mantle-Cell 24 Lymphoma, Large B-Cell, Diffuse 24 Lymphoma, Large-Cell, Immunoblastic 23 Burkitt Lymphoma 23 Sezary Syndrome 22 Mycosis Fungoides 22 Leukemia, Myeloid, Acute 22 Hodgkin Disease 22 Multiple Myeloma 21 Congenital Abnormalities 21 Myeloproliferative Disorders 18 Lymphoma, Extranodal NK-T-Cell 18 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17 Leukemia, Myeloid, Chronic-Phase 17 Leukemia, Myeloid, Accelerated Phase 17 Lymphoma, Large-Cell, Anaplastic 16 Waldenstrom Macroglobulinemia 15 Leukemia, Myelomonocytic, Chronic 15 Dendritic Cell Sarcoma, Interdigitating 15 Recurrence 14 Lymphoma 14 Leukemia 14 Immunoblastic Lymphadenopathy 14 Leukemia, Myelomonocytic, Juvenile 13

Interventions

pembrolizumab 23 Nivolumab 20 aldesleukin 19 Cyclophosphamide 18 Ipilimumab 16 Interleukin-2 15 fludarabine 14 fludarabine phosphate 12 cemiplimab 11 Radiotherapy 7 Biopsy 7 dabrafenib 6 Surveys and Questionnaires 6 Fluorouracil 6 Dacarbazine 6 trametinib 5 binimetinib 5 Vemurafenib 5 Surgical Procedures, Operative 5 Radiation 5 Blood Specimen Collection 5 Aminolevulinic Acid 5 encorafenib 4 Temozolomide 4 Sirolimus 4 Photochemotherapy 4 Educational Status 4 sonidegib 3 montanide ISA 51 3 avelumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00866684 2025-03-14

PROSKIN

Charite University, Berlin, Germany

Phase 4 Terminated

44 enrolled 7 charts

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡